T. Rowe Price Associates’s Colony Capital, Inc. CLNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-19,800
Closed -$401K 2643
2016
Q4
$401K Sell
19,800
-15,200
-43% -$298K ﹤0.01% 2141
2016
Q3
$638K Sell
35,000
-640,910
-95% -$11.3M ﹤0.01% 1915
2016
Q2
$10.4M Buy
675,910
+2,620
+0.4% +$45.5K ﹤0.01% 1285
2016
Q1
$11.3M Sell
673,290
-2,050
-0.3% -$34.4K ﹤0.01% 1244
2015
Q4
$13.2M Sell
675,340
-1,970
-0.3% -$40.1K ﹤0.01% 1219
2015
Q3
$13.2M Buy
677,310
+4,870
+0.7% +$108K ﹤0.01% 1233
2015
Q2
$15.2M Buy
672,440
+2,600
+0.4% +$66.1K ﹤0.01% 1224
2015
Q1
$17.4M Sell
669,840
-5,410
-0.8% -$136K ﹤0.01% 1180
2014
Q4
$16.1M Buy
675,250
+8,000
+1% +$186K ﹤0.01% 1181
2014
Q3
$14.9M Sell
667,250
-300
-0% -$6.75K ﹤0.01% 1196
2014
Q2
$15.5M Sell
667,550
-56,180
-8% -$1.23M ﹤0.01% 1194
2014
Q1
$15.9M Buy
723,730
+1,750
+0.2% +$38.5K ﹤0.01% 1175
2013
Q4
$14.6M Buy
721,980
+7,280
+1% +$147K ﹤0.01% 1179
2013
Q3
$14.3M Sell
714,700
-8,400
-1% -$170K ﹤0.01% 1176
2013
Q2
$14.4M Buy
+723,100
New +$15.8M ﹤0.01% 1164

Other funds holding CLNY

T. Rowe Price Associates's CLNY Position: Q1 2017 in Review

T. Rowe Price Associates sold out of Colony Capital, Inc. (CLNY) in Q1 2017, closing a stake of 19,800 shares — an estimated $401K sold.

T. Rowe Price Associates first reported a position in CLNY in Q2 2013 and held it in 15 quarters. The position peaked at $17.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold CLNY as of Q1 2017.

  • T. Rowe Price Associates reported no remaining Colony Capital, Inc. position as of Q1 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 19,800 Colony Capital, Inc. shares in Q1 2017, an estimated $401K.
  • T. Rowe Price Associates first reported a position in Colony Capital, Inc. in Q2 2013 and held it in 15 quarters.
  • T. Rowe Price Associates's Colony Capital, Inc. position peaked at $17.4M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Colony Capital, Inc. as of Q1 2017.

Based on T. Rowe Price Associates's 13F filing for Q1 2017, filed 15 May 2017.